Answers are grounded in this paper and cite their sources.
. These results suggest that PD-L1 on EVs may be another mechanism for glioblastoma to suppress antitumor immunity and support the potential of EVs as biomarkers in tumor patients.
No takes yet. Share an insight, caveat, or question.
Ricklefs et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: